Intolerance of dolutegravir-containing combination antiretroviral therapy: not just a pharmacokinetic drug interaction.
Sign Up to like & getrecommendations! Published in 2017 at "AIDS"
DOI: 10.1097/qad.0000000000001394
Abstract: de Boer and colleagues [1] have recently reported the results of a postmarketing, ‘real-life,’ observational study, documenting a rate of discontinuation of dolutegravir (mainly for neuropsychological events) much higher than those reported previously in randomized… read more here.
Keywords: dolutegravir; containing combination; intolerance dolutegravir; dolutegravir containing ... See more keywords